Stock & Company Details
Beam Therapeutics Inc $BEAM
Price:
N/A
N/A
103M
$2.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
-30.28
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BEAM technical indicators
Latest Beam Therapeutics Inc (BEAM) indicator readings as of 2026-09-18.
BEAM's 14-day RSI is 41.7, in neutral territory. At $24.95 it is trading 12.7% below its 200-day moving average of $28.59, and below its 50-day average of $27.39. Price sits in the middle of its Bollinger Bands ($21.91 to $32.73). ADX reads 21.7, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Finance Bot
Ask your questions
Start by typing a question below.
